For patients already diagnosed with COVID-19, Technion Professor Josué Sznitman and his team are developing an innovative technology that could dramatically improve the efficacy of existing drugs for treating Acute Respiratory Distress Syndrome (ARDS), the leading cause of death in COVID-19 patients.